Balance Sheet
Accounts PayablesAssetsCommon EquityLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Non-Current Assets (2023 - 2025)

Lamy (LMMY) has disclosed Non-Current Assets for 3 consecutive years, with $22.1 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 308862.73% to $22.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.1 million through Nov 2025, up 308862.73% year-over-year, with the annual reading at $14489.0 for FY2024, 50.36% down from the prior year.
  • Non-Current Assets hit $22.1 million in Q4 2025 for Lamy, up from $7137.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $22.1 million in Q4 2025 to a low of $7137.0 in Q4 2024.
  • Historically, Non-Current Assets has averaged $2.5 million across 3 years, with a median of $21839.0 in 2023.
  • Biggest five-year swings in Non-Current Assets: crashed 67.32% in 2024 and later soared 308862.73% in 2025.
  • Year by year, Non-Current Assets stood at $21839.0 in 2023, then plummeted by 67.32% to $7137.0 in 2024, then skyrocketed by 308862.73% to $22.1 million in 2025.
  • Business Quant data shows Non-Current Assets for LMMY at $22.1 million in Q4 2025, $7137.0 in Q4 2024, and $10813.0 in Q3 2024.